Facebook Pixel Tracker

ACT-TRIPLAN Laboratories (Europe)

ACT-TRIPLAN Laboratories (Europe)

European Expertise in Rodent & Insect Control – Introduced to Pakistan by The Veterinary News & Views

Thank you for reading this post, don't forget to subscribe!
Published on The Veterinary News & Views – International Product & Technology Desk
Introduced following professional engagement at VIV MEA Abu Dhabi

Company Overview

ACT-TRIPLAN Laboratories is a Europe-based specialist manufacturer of professional rodenticides, insecticides, repellents, and bait station systems. The company operates across Europe, Africa, Asia, and Latin America, providing regulatory-compliant pest control solutions aligned with EU Biocidal Regulation (EU) No. 528/2012.

Product Portfolio

Rodenticides
Wax blocks, grain baits, pellets, fresh pasta baits, bulk & sachet formats
Insecticides
Liquid and aerosol formulations for indoor and outdoor professional use
Repellents
Snake, dog, and cat repellent solutions
Bait Stations
Professional, tamper-resistant, customizable bait boxes

Regulatory & Technical Strength

ACT-TRIPLAN products are supported by full regulatory dossiers, Safety Data Sheets (SDS), and technical documentation. Active ingredients include Difenacoum, Brodifacoum, and Bromadiolone, formulated to European safety and efficacy standards.

Technical Documents & Product Profiles

Official documents received from the company (for professional reference):

Relevance for Pakistan

Pakistan’s livestock, poultry, food processing, and municipal sectors face increasing pest-related challenges. The introduction of ACT-TRIPLAN through VNV provides industry stakeholders with insight into international pest management standards, supporting informed discussion and future planning.

Disclaimer:
This publication is intended strictly for professional awareness and international industry reference. Product availability, registration, distribution, or use in Pakistan is subject to approval by relevant regulatory authorities. The Veterinary News & Views does not claim commercial representation unless formally announced.